Chemomab Therapeutics (CMMB) Operating Leases (2019 - 2025)
Chemomab Therapeutics posted quarterly Operating Leases of $113000.0 for Q1 2025, up 2.73% year-on-year from $110000.0 in Q1 2024, and down 45.93% on a QoQ basis from $209000.0 in Q4 2024.
Chemomab Therapeutics (CMMB) has 7 years of Operating Leases data on file, last reported at $113000.0 in Q1 2025.
- For the quarter ending Q1 2025, Operating Leases rose 2.73% year-over-year to $113000.0; the trailing twelve-month figure through Mar 2025 stood at $113000.0 (up 2.73% YoY), and the FY2024 full-year result was $209000.0, down 46.68% from the prior year.
- Operating Leases for Q1 2025 stood at $113000.0, down from $209000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $392000.0 in Q4 2023 and bottomed at $62000.0 in Q1 2023.
- The 5-year median for Operating Leases is $148000.0 (2022), against an average of $193647.1.
- The widest annual swing landed in 2021, when Operating Leases surged 373.02%; it then plunged 69.46% in 2023.
- A 5-year view of Operating Leases shows it stood at $343000.0 in 2021, then plunged by 37.61% to $214000.0 in 2022, then soared by 83.18% to $392000.0 in 2023, then plunged by 46.68% to $209000.0 in 2024, then slumped by 45.93% to $113000.0 in 2025.
- The last three Operating Leases figures came in at $113000.0 (Q1 2025), $209000.0 (Q4 2024), and $112000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 113,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 109,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 392,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 108,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 214,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 203,000.00 |
| Dec 31, 2021 | 343,000.00 |
| Sep 30, 2021 | 298,000.00 |
| Jun 30, 2021 | 320,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Jun 30, 2020 | 108,000.00 |
| Mar 31, 2020 | 152,000.00 |
| Dec 31, 2019 | 725,000.00 |
| Sep 30, 2019 | 992,000.00 |
| Jun 30, 2019 | 1.05 Mn |